(Q37965722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

mRNA vaccination as a safe approach for specific protection from type I allergy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Sandra Scheiblhofer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Elisabeth Roesler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Esther Weinberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Josef Thalhamer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

55-67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

IgE in allergy and asthma today

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

21 January 2018

IL-5 and eosinophilia.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

An interaction between filaggrin mutations and early food sensitization improves the prediction of childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Association of polymorphisms of toll-like receptor 4 with a reduced prevalence of hay fever and atopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Allergic disease and sensitization in Steiner school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community. SCARPOL team. Swiss Study on Childhood Allergy and Respiratory Symptoms with Respect to Air Pollution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Environmental exposure to endotoxin and its relation to asthma in school-age children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Austrian children living on a farm have less hay fever, asthma and allergic sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Reduced risk of hay fever and asthma among children of farmers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Arabinogalactan isolated from cowshed dust extract protects mice from allergic airway inflammation and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

High levels of grass pollen inside European dairy farms: a role for the allergy-protective effects of environment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Not all farming environments protect against the development of asthma and wheeze in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Microbial exposure of rural school children, as assessed by levels of N-acetyl-muramic acid in mattress dust, and its association with respiratory health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Animal shed Bacillus licheniformis spores possess allergy-protective as well as inflammatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

The current state of recombinant allergens for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Prediction of sensitization to inhalant allergens in childhood: evaluating family history, atopic dermatitis and sensitization to food allergens. The MAS Study Group. Multicentre Allergy Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

House dust mite-specific T cells in healthy non-atopic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunological mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Peptide induces CD4(+)CD25+ and IL-10+ T cells and protection in airway allergy models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunotherapy of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Short-term preseasonal birch pollen allergoid immunotherapy influences symptoms, specific nasal provocation and cytokine levels in nasal secretions, but not peripheral T-cell responses, in patients with allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Vaccination with the recombinant allergen ProDer p 1 complexed with the cationic lipid DiC14-amidine prevents allergic responses to house dust mite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

MVA and NYVAC as vaccines against emergent infectious diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Vaccination with a Modified Vaccinia Virus Ankara-based vaccine protects mice from allergic sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

DNA vaccines for the prevention and treatment of allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Is genetic vaccination against allergy possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Absence of immunoglobulin E synthesis and airway eosinophilia by vaccination with plasmid DNA encoding ProDer p 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunization with a low-dose replicon DNA vaccine encoding Phl p 5 effectively prevents allergic sensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Characterization of the ribonuclease activity on the skin surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Immunize and disappear-safety-optimized mRNA vaccination with a panel of 29 allergens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Plasmid DNA- and messenger RNA-based anti-cancer vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

mRNA as gene therapeutic: how to control protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

DNA and RNA-based vaccines: principles, progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Role of TLR3 in the immunogenicity of replicon plasmid-based vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Uptake and trafficking of DNA in keratinocytes: evidence for DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Endocytosis of DNA-Hsp65 alters the pH of the late endosome/lysosome and interferes with antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Spontaneous uptake of biologically active recombinant DNA by mammalian cells via a selected DNA segment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Protein expression from exogenous mRNA: uptake by receptor-mediated endocytosis and trafficking via the lysosomal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Nucleocytoplasmic transport of plasmid DNA: a perilous journey from the cytoplasm to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Intralymphatic immunization enhances DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Prophylactic mRNA vaccination against allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

T cell memory is short-lived in the absence of antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Interaction and mutual stabilization of the two subunits of vaccinia virus mRNA capping enzyme coexpressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Farm living: effects on childhood asthma and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Expression of CD14 and Toll-like receptor 2 in farmers' and nonfarmers' children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Cord blood allergen-specific IgE is associated with reduced IFN-γ production by cord blood cells: The Protection against Allergy—Study in Rural Environments (PASTURE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.168

21 January 2018

Identifiers

DOI

10.1586/ERV.11.168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22149709%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference